Monday, October 24, 2016
Cobalt Dichloride Shortage Minimize

There is a potential shortage issue of Cobalt Dichloride, a critical substance, which is used in fermentation, by Biopharmaceutical manufacturers due to a lack of knowledge of the European Commission's REACh initiative.

The ECHA (European Chemicals Agency) is leading the implementation of the REACh (Registration, Evaluation and Authorization of Chemicals) legislation throughout Europe. The REACh process includes several steps including the inclusion of SVHCs (Substance of Very High Concern) on Authorization or Restriction lists for the substances for a specific use.


All industries are expected to do their due diligence to assure upstream, downstream or importer users, comply with the legislation.


One of the substances that is to be included on the Authorization list in February 2013 and for which industries will need to apply for authorization for use for a specific area is the essential substance Cobalt Dichloride.


Firms who purchase Cobalt Dichloride from a European supplier or use Cobalt Dichloride to manufacturer a product in Europe are specifically impacted by the requirements of REACh.  Including Cobalt Dichloride as a SVHC may lead some European suppliers to cease production.


To learn more about REACH you can go to the following web sites:


European Chemicals Agency: http://echa.europa.eu/


Cobalt REACH Consortium: http://www.cobaltreachconsortium.org/




2009 © Rx-360